(WASHINGTON) -- The Food and Drug Administration on Monday approved Pfizer boosters for 12- to 15-year-olds.
The moves comes as schools reopen after the holiday break.
In a release, the FDA said it has amended the emergency use authorization for the Pfizer vaccine to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six, and to allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.
This is a developing story. Please check back for updates.